Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer

Figure 1

Expression of CDCP1 in paratumor and BrCa tissues. (a) Comparison of CDCP1 mRNA expression in paratumor and BrCa tissues in the TCGA dataset based on data mining via UALCAN. (b) Comparison of CDCP1 protein expression in paratumor and BrCa tissues in the CPTAC dataset based on data mining via UALCAN. (c) Representative images revealing CDCP1 expression in tumor and paratumor tissues using anti-CDCP1 staining. (d) Expression levels of CDCP1 in tumor and paratumor tissues in the in-house cohort.

(a)

(b)

(c)

(d)